Table 3.
Bivariate and multivariate logistic regression for associated variables for elevated ALT
| Variables | Elevated ALT N(%) | Univariate COR 95% CI | Multivariate AOR (95% CI) |
|---|---|---|---|
| Sex | |||
| Female (n = 120) | 10 (9.0) | 0.5 (0.22-1.30) | 0.36 (0.03-2.7) |
| male (n = 133) | 19 (14.3) | ||
| ART status | |||
| On ART (n = 222) | 27 (12.2) | 1.6 (0.35-7.3) | 2.0 (0.43-6.8) |
| Not on ART (n = 31) | 2 (6.4) | 1.0 | |
| Residence | |||
| Urban (n = 169) | 16 (9.4) | 1.0 | |
| Rural (n = 84) | 13 (15.4) | 0.51 (0.22-1.2) | 3.2 (1.2-8.2)* |
| HBSAg | |||
| Positive (n = 5) | 3 (60) | 1.9 (0.22-18.1) | 0.49 (0.06-4.3) |
| Negative (n = 248) | 26 (10.5) | 1.0 | |
| Anti-HCV Ab | |||
| Positive (n = 14) | 3 (21.4) | 2.3 (0.4-10.0) | 1.6 (0.22-11.5) |
| Negative (n = 239) | 26 (5.8) | 1.0 | |
| Anti-HCV or HBsAg | |||
| Positive (n = 19) | 6 | 3.2 (1.4-14.2) | 4.7 (1.5-13.5)** |
| Negative (n = 234) | 23 | 1.0 |
*: P value 0.01 and **P value = 0.001; ART: antiretroviral therapy; AOR: adjusted odds ratio; COR: crud odds ratio; anti-hepatitis C virus antibodies; CI: confidence interval.